Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 716

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT03879694
Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neur…
Incomplete Freund's Adjuvant Cancer Phase 1 COMPLETED En attente / non publié Roswell Park Cancer Institute United States · Roswell Park Cancer Institute, Buffal… 2019-06-17 → 2025-03-14 Ouvrir
NCT04233294
Addition of Chidamide to the Combination Treatment of Decitabine Plus C…
Chidamide Cancer Phase 2 UNKNOWN En attente / non publié Chinese PLA General Hospital China · Biotherapeutic Department of Chinese PLA Gene… 2020-02-02 → 2026-02 Ouvrir
NCT03882866
Iodine-125 Seed Implantation Therapy for Locally Advanced Pancreatic Ca…
3D-printed non-coplanar template Cancer NA UNKNOWN En attente / non publié Ruijin Hospital China · Anhui Provincial Hospital, Hefei, China | Chi… 2019-03-28 → 2021-09-30 Ouvrir
NCT05817994
Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry
Endoscopic Ultrasound Guided Live… Cancer À vérifier WITHDRAWN En attente / non publié Sheikh Shakhbout Medical City Non communiqué 2023-04-01 → 2023-04-01 Ouvrir
NCT00861705
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by D…
Bevacizumab Cancer Phase 2 COMPLETED En attente / non publié Genentech, Inc. United States · Abbott-Northwestern Hospital, Minneap… 2009-07-21 → 2025-09-02 Ouvrir
NCT06746623
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chr…
Nonendoscopic Screening for Barre… SEP NA RECRUITING En attente / non publié Louis Stokes VA Medical Center United States · VA Northeast Ohio Healthcare System, … 2025-04-11 → 2028-12-31 Ouvrir
NCT02867397
Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Pati…
Teysuno (S1) in combination with … Cancer Phase 1 COMPLETED En attente / non publié Disphar International B.V. Non communiqué 2012-01 → 2015-08 Ouvrir
NCT05982574
Tumor Microenvironment
Tumor Microenvironment Cancer À vérifier ACTIVE_NOT_RECRUITING En attente / non publié University Hospital Heidelberg Non communiqué 2016-02 → 2026-12 Ouvrir
NCT00776074
A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Fema…
Leuprorelin (GF) Cancer Phase 2 COMPLETED En attente / non publié Takeda Non communiqué 2006-06 → 2007-07 Ouvrir
NCT05392374
Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Ponti…
ONC201 Cancer À vérifier NO_LONGER_AVAILABLE En attente / non publié Jazz Pharmaceuticals United States · Albany Medical Center, Albany, United… Non communiqué Ouvrir
NCT03543397
MRI in Ductal Carcinoma in Situ (DCIS)
MRI in Ductal Carcinoma in Situ (… Cancer À vérifier UNKNOWN En attente / non publié University Hospital, Strasbourg, … France · Service de Radiologie 1, Strasbourg, France 2018-02-26 → 2019-02 Ouvrir
NCT00652080
An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ …
API 31510 Cancer Phase 1 COMPLETED En attente / non publié BPGbio United States · Burke Pharmaceuticals, Hot Springs, U… 2008-06 → 2010-01 Ouvrir
NCT00003980
BIBX 1382 in Treating Patients With Solid Tumors
BIBX 1382 Cancer Phase 1 SUSPENDED En attente / non publié European Organisation for Researc… Austria, Belgium, Denmark, France, Germany, Netherlan… 1999-02 Ouvrir
NCT03613259
Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or Hi…
Fluorothymidine F-18 Cancer Phase 1 WITHDRAWN En attente / non publié OHSU Knight Cancer Institute Non communiqué 2020-06-01 → 2022-06-01 Ouvrir
NCT06979180
A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on…
A Clinical Trial to Investigate t… Cancer NA RECRUITING En attente / non publié Papillex Inc. Canada · KGK Science Inc., London, Canada 2026-03 → 2026-12 Ouvrir
NCT02258659
Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy…
paclitaxel albumin-stabilized nan… Cancer Phase 2 COMPLETED En attente / non publié University of Chicago United States · University of Chicago, Chicago, Unite… 2014-09-22 → 2024-09-06 Ouvrir